Podcasts
Blog
Podcasts
Blog
ASH 2022: David Sallman, MD, Discusses Positive Phase I Dose Escalation Data for PRGN-3006 UltraCAR-T in AML Patients
12.20.2022 -
By
Download our free app to listen on your phone
More episodes from Oncology Times - OncTimes Talk